Hidradenitis Suppurativa: Remibrutinib Study

We are testing the effectiveness and safety of remibrutinib in adults with moderate to severe hidradenitis suppurativa. The study aims to see if it helps reduce symptoms like flare-ups and skin pain compared to a placebo.

1-2 years 11-15 visits Confirmation phase (III)Post-Trial Drug Access Cost Reimbursement Partially Remote Investigational Medicines OralAllergologyDermatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Clindamycin

Clindamycin is an antibiotic medicine used to treat various bacterial infections, including skin and respiratory infections.

Triamcinolone Acetonide Medipha

Triamcinolone Acetonide Medipha is a steroid medicine used to reduce inflammation and relieve itching in skin conditions like eczema and rashes.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Clindamycin

Clindamycin is an antibiotic substance used to treat various bacterial infections, including skin and respiratory infections.

Clindamycin Hydrochloride

Clindamycin hydrochloride is an antibiotic substance used to treat various bacterial infections, particularly skin, soft tissue, and certain respiratory infections.

Clindamycin Phosphate

Clindamycin phosphate is an antibiotic substance used to treat bacterial infections, including skin infections and acne.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Remibrutinib

Lou064

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Adcortyl Intra-Articular / Intradermal Injection

Adcortyl Intra-Articular/Intradermal

Aknet Duo

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Umbal - Prof. D-R Stoyan Kirkovich AD

3002: Dermatology and Venereology clinic

Kardzhali, Bulgaria

Medical Center Kordis OOD

3003

Pleven, Bulgaria

Acibadem City Clinic Tokuda University Hospital EAD

3004: Clinic of Dermatology and Venereology disease

Sofia, Bulgaria

Sponsor: Novartis Pharma AG

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.